Preemptive drug should be routine in AIDS fight: study

Candles form a red ribbon in Berlin, on November 30, 2013 during the World Aids DayGay men at high risk of contracting HIV should have access to a daily dose of a drug used to treat the AIDS-causing virus, but as a preventive measure, researchers recommended Thursday. The medicine, sold under the brand name Truvada, proved almost 90 percent effective at protecting men taking part in a British study, they wrote in The Lancet medical journal. There is also the prohibitive cost: a year's supply of Truvada, in a western European country, would cost around 7,000 euros ($ 7,700).



Sexual Health News Headlines – Yahoo! News